B&E Bio-Technology Presents Hematology and Clinical Diagnostic Analyzers

By LabMedica International staff writers
Posted on 17 Nov 2026

B&E Bio-Technology (Yantai, Shandong, China) is showcasing its portfolio of laboratory and point-of-care diagnostic instruments at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. At Hall 3, Stand F92-5, the company is highlighting five systems covering hematology, blood gas testing, electrolyte measurement, and glycated hemoglobin analysis. These instruments are designed to support routine laboratory testing, patient monitoring, and decentralized diagnostic applications.

Among the featured products is the Hemax 530AL automatic hematology analyzer, a five-part differential system capable of measuring 29 parameters at a throughput of up to 80 samples per hour. The analyzer combines semiconductor laser flow cytometry, electrical impedance, and cyanide-free hemoglobin measurement. It features an automatic sample loader, supports whole blood and capillary blood testing with sample volumes of 20 µL or less, and offers bidirectional laboratory information system (LIS) connectivity. B&E is also presenting the Hemax 580, another automated hematology analyzer designed to support routine blood cell analysis and differential leukocyte counting in clinical laboratories.


Image: For point-of-care testing, B&E is highlighting the handheld i-Check 200 blood gas analyzer, which uses disposable cartridges and dry electrochemical measurement technology (Photo courtesy of B&E Bio-Technology )

For point-of-care testing, B&E is highlighting the handheld i-Check 200 blood gas analyzer, which uses disposable cartridges and dry electrochemical measurement technology. The portable system measures blood gases, electrolytes, glucose, lactate, hematocrit, and other parameters using approximately 95 µL of blood, with results available in 60 seconds or less. It supports arterial, venous, and capillary blood samples and is designed for use in settings such as emergency departments, intensive care units, and bedside testing.

The company is also exhibiting its CBS Series electrolyte analyzers, which incorporate an all-in-one biosensor electrode design for electrolyte testing. These instruments support the measurement of electrolyte concentrations to assist in assessing fluid and electrolyte balance. Their integrated electrode configuration is intended to simplify routine testing and instrument operation.

Completing the exhibit is the G60 glycated hemoglobin analyzer, which uses high-performance liquid chromatography (HPLC) to measure hemoglobin A1c (HbA1c). The system provides laboratory measurements used in diabetes diagnosis and long-term glycemic monitoring. Together, these five instruments reflect B&E Bio-Technology's portfolio of automated and point-of-care diagnostic technologies for clinical laboratory and healthcare applications.


Latest Medica 2026 News